MAGNIMS Workshop
September 10, 2021
8.30-8.40 Introduction C Gasperini
8.40-9.00 Demographic & clinical factors in the assessment of MS prognosis M Tintoré
Download file attached
9.00–9.20 How neuropathology help us to interpret MRI data in the assessment of MS prognosis R Magliozzi
Download file attached
9.20-10.20 What we know Chairs: M Filippi – H Vrenken
9.20-9.40 T2 and T1 lesions: does topography matter? F Barkhof
9.40-10.00 Cortical lesions M Calabrese
10.00-10.20 Brain and spinal cord atrophy N De Stefano
10.20-11.20 What we need to know Chairs: M Rocca B Stankoff
10.20-10.40 Non-conventional MRI and MS prognosis DTI and MTR C Enzinger
10.40-11.00 Non-conventional MRI and MS prognosis. Functional and Structural MRI Connectivity D Chard
11.00-11.20 Non-conventional MRI and MS prognosis PET MRI B Bodini
11.20-11.40 Coffee break
11.40-12.20 Novel approaches Chairs: A Rovira J Kuhle
11.40-12.00 Lesion characterization: from black holes to SWI imaging T Yousry
12.00-12.20 Cerebrospinal fluid and serum biomarker (OB-neurofilaments immunological biomarkers) L Battistini
12.20-13.00 Multimodal approaches Chairs: J Sastre-Garriga J Palace
12.20-12.40 A Multiparemeter model to assess prognosis: its potential role in the treatment indications C Gasperini
12.40-13.00 How to create a multiparameter model to be applied in the clinical setting: the role of the statistician MP Sormani
13.00-13.20 Wrap up MAGNIMS Steering Committee
Additional discussants: L Kappos, O Ciccarelli, L Prosperini, C Tortorella, S. Ruggeri
13.20-14.20 Lunch
